Siirry pääsisältöön
Käyttämääsi selainta ei enää tueta – lue lisää.
0,0026DKK
0,00% (0,0000)
Päätöskurssi
Ylin0,0028
Alin0,0026
Vaihto
0 MDKK
0,0026DKK
0,00% (0,0000)
Päätöskurssi
Ylin0,0028
Alin0,0026
Vaihto
0 MDKK
0,0026DKK
0,00% (0,0000)
Päätöskurssi
Ylin0,0028
Alin0,0026
Vaihto
0 MDKK
0,0026DKK
0,00% (0,0000)
Päätöskurssi
Ylin0,0028
Alin0,0026
Vaihto
0 MDKK
0,0026DKK
0,00% (0,0000)
Päätöskurssi
Ylin0,0028
Alin0,0026
Vaihto
0 MDKK
0,0026DKK
0,00% (0,0000)
Päätöskurssi
Ylin0,0028
Alin0,0026
Vaihto
0 MDKK
2025 H1 -tulosraportti
178 päivää sitten

Tarjoustasot

Määrä
Osto
-
Myynti
Määrä
-

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
29 615--
163 158--
2 586 842--
950 384--
16 369--
Ylin
0,003
VWAP
0,003
Alin
0,003
VaihtoMäärä
0 5 638 257
VWAP
0,003
Ylin
0,003
Alin
0,003
VaihtoMäärä
0 5 638 257

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt

Yhtiötapahtumat

Datan lähde: Quartr
Seuraava tapahtuma
Sijoittajakalenteri ei ole saatavilla
Menneet tapahtumat
2025 H1 -tulosraportti
4.9.2025
2024 H2 -tulosraportti
29.4.2025
2024 H1 -tulosraportti
3.9.2024
2023 H2 -tulosraportti
7.5.2024
2023 H1 -tulosraportti
1.9.2023

Shareville

Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
  • 1 päivä sitten
    ·
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    Let's hope Fiona delivers on the promise from the 2024 annual report, which promised us NHS contracts signed and paid within 12-18 months, i.e., by June 2026 at the latest. I believe in it, as Devika has told me by email that they have received the grant of £100,000, which I recall is given to a project in a part of the NHS, with 28000 patients, who were to test the use of Ayla on patients, before they could receive a dementia diagnosis.
    3 t sitten
    ·
    3 t sitten
    ·
    I don't think they received the grant without there being an assurance that the company exists while the project is ongoing.
  • 2 päivää sitten
    ·
    2 päivää sitten
    ·
    https://avisen.nu/fredericianer-med-demens-tog-ordet-paa-christiansborg-jeg-kan-ikke-bare-saette-mig-i-sofaen-og-gemme-mig/ Proud to have a father who does everything he can to focus on dementia and spread the message. 🙌
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    Fantastic. Thanks to your father. Does your father receive CST or other offers from the municipality in everyday life?
    5 t sitten
    ·
    5 t sitten
    ·
    Many thanks for that Mikkel. If so, please write to fundbrainplus@gmail.com, and you can get a mailing list for the politicians who are currently looking into whether Ayla and thus CST and MCST, can be helped along with state aid. I know that many of them participated in the hearing, but if they can read, for example, your story about CST and how it helped your father and those around him, the decision will probably be easier for them, just as we want to be sure they can recall your father's story.
  • 2 päivää sitten
    ·
    2 päivää sitten
    ·
    With Ayala, Brain has chosen to focus on the institutional market with nursing homes, etc. As I understand it, B has actually been working on a version aimed at the private market, where relatives themselves are responsible for the care of either their demented father/mother at home. However, the development of this version is said to have been put on hold. Is there anyone here who has an idea of how far this home version is from being ready? When I ask, it's because I'm wondering how much value that version represents in a quick separate divestment. The more I think about it, the more I'm convinced that B has unfortunately bet on the wrong horse by focusing on the institutional market. I am convinced that the gold lies in the private market, which is larger, presumably easier to penetrate, and should also be more lucrative with larger margins. I pensionereded myself quite early and am mostly inclined to enjoy life, among other things, by flying to Barcelona approximately every other weekend to sit at Nou Camp. But had I been younger, I probably wouldn't have hesitated long before bidding on the aforementioned private version.
    1 päivä sitten
    1 päivä sitten
    Tämä kommentti on poistettu.
    2 päivää sitten
    ·
    2 päivää sitten
    ·
    Mingodk, they made a forced choice due to limited resources. One cannot criticize that. Just my feeling, I think they, as I said, ended up betting on the wrong horse, a feeling which is also based on how difficult it has proven to penetrate that market. But one cannot criticize their choice either, because one probably couldn't have known that beforehand. BUT, if that version is far along, or relatively far along, then it should represent a decent value upon divestment. Even a million or two would be a great help in the situation Brain is in. In this regard, one could read in people's comments about the webinar that the lawyer thought it could be a great help if a larger investor led the way with a decent amount. As I see it, this investor could get good security for his outlay in such a way that he says: OK, here you have 4-5 million. In return for that, I will then have ownership of the private version. If all goes well, this major investor with this model might get 2 gains. 1) his current shareholding in Brain retains a certain value provided the 4-5 million ends up saving Brain and 2) the person can himself develop the private version within an entity.
  • 3 päivää sitten
    ·
    3 päivää sitten
    ·
    An unusable answer is better than no answer
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Uutiset

Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Tuotteita joiden kohde-etuutena tämä arvopaperi

2025 H1 -tulosraportti
178 päivää sitten

Uutiset

Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Shareville

Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
  • 1 päivä sitten
    ·
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    Let's hope Fiona delivers on the promise from the 2024 annual report, which promised us NHS contracts signed and paid within 12-18 months, i.e., by June 2026 at the latest. I believe in it, as Devika has told me by email that they have received the grant of £100,000, which I recall is given to a project in a part of the NHS, with 28000 patients, who were to test the use of Ayla on patients, before they could receive a dementia diagnosis.
    3 t sitten
    ·
    3 t sitten
    ·
    I don't think they received the grant without there being an assurance that the company exists while the project is ongoing.
  • 2 päivää sitten
    ·
    2 päivää sitten
    ·
    https://avisen.nu/fredericianer-med-demens-tog-ordet-paa-christiansborg-jeg-kan-ikke-bare-saette-mig-i-sofaen-og-gemme-mig/ Proud to have a father who does everything he can to focus on dementia and spread the message. 🙌
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    Fantastic. Thanks to your father. Does your father receive CST or other offers from the municipality in everyday life?
    5 t sitten
    ·
    5 t sitten
    ·
    Many thanks for that Mikkel. If so, please write to fundbrainplus@gmail.com, and you can get a mailing list for the politicians who are currently looking into whether Ayla and thus CST and MCST, can be helped along with state aid. I know that many of them participated in the hearing, but if they can read, for example, your story about CST and how it helped your father and those around him, the decision will probably be easier for them, just as we want to be sure they can recall your father's story.
  • 2 päivää sitten
    ·
    2 päivää sitten
    ·
    With Ayala, Brain has chosen to focus on the institutional market with nursing homes, etc. As I understand it, B has actually been working on a version aimed at the private market, where relatives themselves are responsible for the care of either their demented father/mother at home. However, the development of this version is said to have been put on hold. Is there anyone here who has an idea of how far this home version is from being ready? When I ask, it's because I'm wondering how much value that version represents in a quick separate divestment. The more I think about it, the more I'm convinced that B has unfortunately bet on the wrong horse by focusing on the institutional market. I am convinced that the gold lies in the private market, which is larger, presumably easier to penetrate, and should also be more lucrative with larger margins. I pensionereded myself quite early and am mostly inclined to enjoy life, among other things, by flying to Barcelona approximately every other weekend to sit at Nou Camp. But had I been younger, I probably wouldn't have hesitated long before bidding on the aforementioned private version.
    1 päivä sitten
    1 päivä sitten
    Tämä kommentti on poistettu.
    2 päivää sitten
    ·
    2 päivää sitten
    ·
    Mingodk, they made a forced choice due to limited resources. One cannot criticize that. Just my feeling, I think they, as I said, ended up betting on the wrong horse, a feeling which is also based on how difficult it has proven to penetrate that market. But one cannot criticize their choice either, because one probably couldn't have known that beforehand. BUT, if that version is far along, or relatively far along, then it should represent a decent value upon divestment. Even a million or two would be a great help in the situation Brain is in. In this regard, one could read in people's comments about the webinar that the lawyer thought it could be a great help if a larger investor led the way with a decent amount. As I see it, this investor could get good security for his outlay in such a way that he says: OK, here you have 4-5 million. In return for that, I will then have ownership of the private version. If all goes well, this major investor with this model might get 2 gains. 1) his current shareholding in Brain retains a certain value provided the 4-5 million ends up saving Brain and 2) the person can himself develop the private version within an entity.
  • 3 päivää sitten
    ·
    3 päivää sitten
    ·
    An unusable answer is better than no answer
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

Määrä
Osto
-
Myynti
Määrä
-

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
29 615--
163 158--
2 586 842--
950 384--
16 369--
Ylin
0,003
VWAP
0,003
Alin
0,003
VaihtoMäärä
0 5 638 257
VWAP
0,003
Ylin
0,003
Alin
0,003
VaihtoMäärä
0 5 638 257

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt

Yhtiötapahtumat

Datan lähde: Quartr
Seuraava tapahtuma
Sijoittajakalenteri ei ole saatavilla
Menneet tapahtumat
2025 H1 -tulosraportti
4.9.2025
2024 H2 -tulosraportti
29.4.2025
2024 H1 -tulosraportti
3.9.2024
2023 H2 -tulosraportti
7.5.2024
2023 H1 -tulosraportti
1.9.2023

Tuotteita joiden kohde-etuutena tämä arvopaperi

2025 H1 -tulosraportti
178 päivää sitten

Uutiset

Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Yhtiötapahtumat

Datan lähde: Quartr
Seuraava tapahtuma
Sijoittajakalenteri ei ole saatavilla
Menneet tapahtumat
2025 H1 -tulosraportti
4.9.2025
2024 H2 -tulosraportti
29.4.2025
2024 H1 -tulosraportti
3.9.2024
2023 H2 -tulosraportti
7.5.2024
2023 H1 -tulosraportti
1.9.2023

Tuotteita joiden kohde-etuutena tämä arvopaperi

Shareville

Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
  • 1 päivä sitten
    ·
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    Let's hope Fiona delivers on the promise from the 2024 annual report, which promised us NHS contracts signed and paid within 12-18 months, i.e., by June 2026 at the latest. I believe in it, as Devika has told me by email that they have received the grant of £100,000, which I recall is given to a project in a part of the NHS, with 28000 patients, who were to test the use of Ayla on patients, before they could receive a dementia diagnosis.
    3 t sitten
    ·
    3 t sitten
    ·
    I don't think they received the grant without there being an assurance that the company exists while the project is ongoing.
  • 2 päivää sitten
    ·
    2 päivää sitten
    ·
    https://avisen.nu/fredericianer-med-demens-tog-ordet-paa-christiansborg-jeg-kan-ikke-bare-saette-mig-i-sofaen-og-gemme-mig/ Proud to have a father who does everything he can to focus on dementia and spread the message. 🙌
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    Fantastic. Thanks to your father. Does your father receive CST or other offers from the municipality in everyday life?
    5 t sitten
    ·
    5 t sitten
    ·
    Many thanks for that Mikkel. If so, please write to fundbrainplus@gmail.com, and you can get a mailing list for the politicians who are currently looking into whether Ayla and thus CST and MCST, can be helped along with state aid. I know that many of them participated in the hearing, but if they can read, for example, your story about CST and how it helped your father and those around him, the decision will probably be easier for them, just as we want to be sure they can recall your father's story.
  • 2 päivää sitten
    ·
    2 päivää sitten
    ·
    With Ayala, Brain has chosen to focus on the institutional market with nursing homes, etc. As I understand it, B has actually been working on a version aimed at the private market, where relatives themselves are responsible for the care of either their demented father/mother at home. However, the development of this version is said to have been put on hold. Is there anyone here who has an idea of how far this home version is from being ready? When I ask, it's because I'm wondering how much value that version represents in a quick separate divestment. The more I think about it, the more I'm convinced that B has unfortunately bet on the wrong horse by focusing on the institutional market. I am convinced that the gold lies in the private market, which is larger, presumably easier to penetrate, and should also be more lucrative with larger margins. I pensionereded myself quite early and am mostly inclined to enjoy life, among other things, by flying to Barcelona approximately every other weekend to sit at Nou Camp. But had I been younger, I probably wouldn't have hesitated long before bidding on the aforementioned private version.
    1 päivä sitten
    1 päivä sitten
    Tämä kommentti on poistettu.
    2 päivää sitten
    ·
    2 päivää sitten
    ·
    Mingodk, they made a forced choice due to limited resources. One cannot criticize that. Just my feeling, I think they, as I said, ended up betting on the wrong horse, a feeling which is also based on how difficult it has proven to penetrate that market. But one cannot criticize their choice either, because one probably couldn't have known that beforehand. BUT, if that version is far along, or relatively far along, then it should represent a decent value upon divestment. Even a million or two would be a great help in the situation Brain is in. In this regard, one could read in people's comments about the webinar that the lawyer thought it could be a great help if a larger investor led the way with a decent amount. As I see it, this investor could get good security for his outlay in such a way that he says: OK, here you have 4-5 million. In return for that, I will then have ownership of the private version. If all goes well, this major investor with this model might get 2 gains. 1) his current shareholding in Brain retains a certain value provided the 4-5 million ends up saving Brain and 2) the person can himself develop the private version within an entity.
  • 3 päivää sitten
    ·
    3 päivää sitten
    ·
    An unusable answer is better than no answer
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

Määrä
Osto
-
Myynti
Määrä
-

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
29 615--
163 158--
2 586 842--
950 384--
16 369--
Ylin
0,003
VWAP
0,003
Alin
0,003
VaihtoMäärä
0 5 638 257
VWAP
0,003
Ylin
0,003
Alin
0,003
VaihtoMäärä
0 5 638 257

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt